TAVR for aortic regurgitation: Moving beyond “off-label” use

FHS
July 13, 2023
1:49 pm

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Transcatheter aortic valve replacement (TAVR) is currently a widely used option for patients with severe symptomatic aortic stenosis with high to low surgical risk.

Bachelorette’s PA School Update; $1,000 X-Ray; Apple Watch OR Hack

The following contains links to social media websites including X, TikTok, Instagram, Facebook, and LinkedIn. Jenn Tran, the upcoming lead on “The Bachelorette,” addressed a

June 28, 2024

Pfizer shelves five mid- and early-stage programs

Pfizer is culling a handful of clinical programs, including trials in cancer and dermatology, it announced Tuesday. The cuts include two Phase II programs, one

November 1, 2023

Top FDA official Peter Marks overruled staff, review team to approve Sarepta gene therapy

For a third time, Sarepta Therapeutics has convinced a top Food and Drug Administration official to overrule the prevailing view of their staff and approve

June 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.